Skip to content

Study · Case report or series · n = 1 · 1987

4 results

[The use of DSIP (delta sleep-inducing peptide) in the correction of phase-shifted insomnia].

Schneider-Helmert D, Hermann E, Schoenenberger GA

Deutsche medizinische Wochenschrift (1946)1 Jun 1987

PMID3582201 (opens in a new tab)DOI10.1055/s-2008-1068167 (opens in a new tab)PepBankPUB-03582201
Publisher pagePubMedAsk about this study
Jump to 4 results

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study4

4 results from studies that gave the peptide. 4 results from people.

  1. 01HumanCase report or seriesEfficacy outcome

    In a 47-year-old woman with chronic delayed sleep phase insomnia, DSIP treatment for one week advanced the main sleep phase by 5 hours.

    In plain wordsIn one woman with delayed sleep phase insomnia, a week of DSIP treatment moved her main sleep period 5 hours earlier.

    Peptide
    Delta sleep-inducing peptide (DSIP)
    Outcome
    IncreaseAdvance of the main sleep phase
    Study

    n = 1

    Outcome group
    Sleep · Sleep
    Studied dose
    Dose not stated · one weekAs given in this study (human).

    Measurements

    Advance of main sleep phase
    5 hours
    DSIP treatment

    Source sentences

    Summary
    advancing the main sleep phase by 5 hours
    1 context sentence
    Summary · context
    A 47-year old woman patient suffering from chronic delayed sleep phase insomnia and low-dose benzodiazepine dependence was treated as an inpatient under close polygraphic control using DSIP (delta sleep inducing peptide) on an intensive-care basis for one week.
  2. 02HumanCase report or seriesEfficacy outcome

    In a 47-year-old woman with low-dose benzodiazepine dependence, DSIP treatment resulted in abrupt and complete withdrawal of flunitrazepam.

    In plain wordsIn one woman with benzodiazepine dependence, DSIP treatment came with a complete and abrupt stop of flunitrazepam.

    Peptide
    Delta sleep-inducing peptide (DSIP)
    Outcome
    DecreaseWithdrawal of flunitrazepam
    Study

    n = 1

    Outcome group
    Addiction, withdrawal and alcohol intake · Mental health and mood
    Studied dose
    Dose not stated · one weekAs given in this study (human).

    Source sentences

    Summary
    an abrupt and complete withdrawal of flunitrazepam and restitution of a normal sleep profile.
    1 context sentence
    Summary · context
    A 47-year old woman patient suffering from chronic delayed sleep phase insomnia and low-dose benzodiazepine dependence was treated as an inpatient under close polygraphic control using DSIP (delta sleep inducing peptide) on an intensive-care basis for one week.
  3. 03HumanCase report or seriesEfficacy outcome

    In a 47-year-old woman with chronic delayed sleep phase insomnia, DSIP treatment resulted in restitution of a normal sleep profile.

    In plain wordsIn one woman with delayed sleep phase insomnia, her sleep profile became normal after a week of DSIP treatment.

    Peptide
    Delta sleep-inducing peptide (DSIP)
    Outcome
    IncreaseRestitution of a normal sleep profile
    Study

    n = 1

    Outcome group
    Sleep · Sleep
    Studied dose
    Dose not stated · one weekAs given in this study (human).

    Source sentences

    Summary
    restitution of a normal sleep profile.
    1 context sentence
    Summary · context
    A 47-year old woman patient suffering from chronic delayed sleep phase insomnia and low-dose benzodiazepine dependence was treated as an inpatient under close polygraphic control using DSIP (delta sleep inducing peptide) on an intensive-care basis for one week.
  4. 04HumanCase report or seriesEfficacy outcome

    In a 47-year-old woman, actographic control during the week after treatment confirmed that the success of the DSIP treatment was maintained.

    In plain wordsIn one woman, activity recording in the week after DSIP treatment showed that the sleep improvement was kept.

    Peptide
    Delta sleep-inducing peptide (DSIP)
    Outcome
    Not applicableMaintenance of treatment success in the week after treatment
    Study

    n = 1

    Outcome group
    Sleep · Sleep
    Studied dose
    Dose not stated · one weekAs given in this study (human).

    Source sentences

    Summary
    Actographic control during an after treatment week confirmed that the success was maintained.
    1 context sentence
    Summary · context
    A 47-year old woman patient suffering from chronic delayed sleep phase insomnia and low-dose benzodiazepine dependence was treated as an inpatient under close polygraphic control using DSIP (delta sleep inducing peptide) on an intensive-care basis for one week.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    12 Oct 2026, 17:28 UTC

    Study results updated

  2. Version 1

    9 Oct 2026, 03:04 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.